Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

doc talking to patient

Contact Us

Call us at 425-899-5385 or use our online information request form.

Online Form

ACTIV-2: A Study for Outpatients With COVID-19, National Institute of Allergy and Infectious Diseases (NIAID)


Goal: To study the safety and effectiveness of different drugs in treating COVID-19 in outpatients.

  • Phase III, randomized, blinded, placebo-controlled trial.
  • Subjects in the study will be treated with either a study drug or with placebo.
  • Multicenter trial with 2000 subject enrollment goal.


Dr. Francis Riedo, EvergreenHealth Infectious Disease Care

Clinical Trial Categories

  • COVID-19